Clinical trial

Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection…

NCT00123734 · Agen Biomedical, Industry · Completed

Key facts

NCT number NCT00123734
Title Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis
Official title Phase II Clinical Trial to Evaluate the Accuracy of Anti-Fibrin Humanized Monoclonal Antibody (DI-DD3B6/22-80B3) Fab' Protein Fragment (ThromboView) Conjugated With Technetium-99m in the Detection of Deep Vein Thrombosis
Lead sponsor Agen Biomedical, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Deep Vein Thrombosis
Intervention type Drug
Interventions ThromboView
Enrollment 94
Start date Mar 1, 2005
Completion May 1, 2006
First posted Jul 26, 2005
Last update posted Aug 24, 2009
Countries Canada, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies